Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Oncol
Hauptverfasser: Mazzu, Ying Z., Armenia, Joshua, Nandakumar, Subhiksha, Chakraborty, Goutam, Yoshikawa, Yuki, Jehane, Lina E., Lee, Gwo‐Shu Mary, Atiq, Mohammad, Khan, Nabeela, Schultz, Nikolaus, Kantoff, Philip W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400792/
https://ncbi.nlm.nih.gov/pubmed/32385899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12706
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge